Latest Headlines

  1. Aprecia And Battelle Are Impacting The Pharmaceutical Industry Through 3D Printing Innovation 3/8/2024

    Aprecia, a precision drug delivery company, has partnered with the research and development experts at Battelle to develop groundbreaking 3D printing platforms with the potential to transform the way medicines are developed, manufactured, distributed, and administered.

  2. Allegheny Performance Plastics® Launches Into Healthcare Sector 3/5/2024

    To meet the growing needs of the healthcare industry, Allegheny Performance Plastics is proud to announce the addition of clean and white room environments, including a dedicated automated work cell to be completed later this year.

  3. Freudenberg Medical Establishes Second Production Facility In Costa Rica 2/15/2024

    Freudenberg Medical, a global contract design and manufacturing (CDMO) partner to the medical device and biopharma industry with facilities in key industry hubs across the Americas, Europe and Asia, announced it is to establish a second manufacturing site in Costa Rica. With this $25 million investment the company is expanding its technologies to deliver increasingly complex products to its global customer base.

  4. Novo Holdings To Acquire CDMO Catalent Pharma Solutions For $16.5 Billion 2/5/2024

    Catalent, Inc. (NYSE: CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, and Novo Holdings, a holding and investment company that is responsible for managing the assets and wealth of the Novo Nordisk Foundation, today announced that they have entered into a merger agreement under which Novo Holdings will acquire Catalent in an all-cash transaction that values Catalent at $16.5 billion on an enterprise value basis.

  5. Aseptic Excellence: Microbiological Validation Seminar Announced For March 14th In Austria 2/2/2024

    Aseptic manufacturing for pharmaceutical and biopharmaceutical products is being regulated and standardized as this practice continues to grow in the industry. With the publication of EU Annex 1 in Europe, there are strict guidelines to assure compliance of the aseptic process.

  6. Solesis To Open First Manufacturing Site In Costa Rica Dedicated To Custom Polymer And Textile Healthcare Solutions 2/2/2024

    The site will expand capabilities to enable development in the fast-growing cardiovascular and advanced therapy markets.

  7. Rob Albert Appointed Chief Executive Officer Of B. Braun Of America Inc. 1/26/2024

    The Board of Directors of B. Braun of America Inc. (“B. Braun of America”) announced today that they have appointed Rob Albert as Chief Executive Officer of B. Braun of America, succeeding Jean-Claude Dubacher who is taking on global management responsibilities, while remaining Chairman of the Board of B. Braun of America. Albert’s appointment will be effective April 1, 2024.

  8. IDEX Health & Science Launches Flow Cytometry Optical Filters 1/24/2024

    IDEX Health & Science has launched the new Semrock® line of Nanopede™ Optical Filters specifically designed for flow cytometry applications.

  9. IDEX Health & Science New Semi-Custom Fluorescence Microscope Imaging Lenses 1/24/2024

    IDEX Health & Science has introduced the new Melles Griot® XPLAN™ CCG Lens Series: semi-custom fluorescence microscope imaging lenses

  10. A Harmonized Understanding Of Annex 1 And USP 1207 – Deploying Package Inspection Methods To Achieve Quality And Compliance” Webinar Announced 12/21/2023

    USP 1207 was formally published in 2017 to encourage the use of deterministic test methods for testing container closure integrity.  In August of 2023, Annex 1 – Manufacture of Sterile Medical Products went live as a regulatory requirement.